|
Title
|
|
|
|
Eosinophil cationic protein and clinical outcome after bare metal stent implantation
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| Objective we assessed the association between baseline eosinophil cationic protein (ECP) levels, a sensitive marker of eosinophil activation, and clinical outcome in patients undergoing bare metal stent (BMS) implantation. Methods basal ECP levels were measured in 110 patients (69 ± 11 years, 88 men) undergoing BMS implantation. Major adverse cardiac events (MACEs), defined as cardiac death, non-fatal myocardial infarction, or clinically-driven target lesion revascularization, were registered at 24-month follow-up. Results eighteen (16.4%) patients had MACEs and showed higher ECP levels compared with those without MACEs [20.1 (9.847.3) vs. 9.5 (5.027.2) g/L, p = 0.02]. At follow-up, ECP level >11 g/L was the only significant predictor of MACEs (HR 3.5, 95% CI 1.110.4, p = 0.03). Conclusion basal ECP levels are associated with MACEs after BMS implantation, suggesting that an allergic-mediated inflammation against the metal could explain some adverse reactions occurring after coronary stenting. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Atherosclerosis. - Amsterdam
| |
|
Publication
|
|
|
|
Amsterdam
:
2011
| |
|
ISSN
|
|
|
|
0021-9150
| |
|
DOI
|
|
|
|
10.1016/J.ATHEROSCLEROSIS.2010.11.044
| |
|
Volume/pages
|
|
|
|
215
:1
(2011)
, p. 166-169
| |
|
ISI
|
|
|
|
000288008700024
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|